<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01852955</url>
  </required_header>
  <id_info>
    <org_study_id>STU00078104</org_study_id>
    <nct_id>NCT01852955</nct_id>
  </id_info>
  <brief_title>Perioperative Systemic Acetaminophen to Improve Postoperative Quality of Recovery After Ambulatory Breast Surgery</brief_title>
  <official_title>Perioperative Systemic Acetaminophen to Improve Postoperative Quality of Recovery After Ambulatory Breast Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent evidence demonstrates that perioperative pain continues to be poorly managed among
      ambulatory surgical patients. More importantly, few interventions that minimize postoperative
      pain have also shown to improve patient overall quality of post-surgical recovery. Ketorolac
      has been used to minimize perioperative pain despite the lack of evidence for its use when
      administered as a single dose preventive strategy.Ketorolac has also been associated with a
      higher incidence of perioperative hematomas and the need for surgical re-exploration after
      breast surgery.

      Systemic acetaminophen has become recently available in The United States. In contrast to
      ketorolac, systemic acetaminophen has not been reported to have adverse side effects on
      patients undergoing breast surgery. Although evidence suggests that a single dose
      perioperative acetaminophen reduces postoperative pain, it remains unknown if a single dose
      intravenous acetaminophen improves postoperative quality of recovery after ambulatory
      surgery.

      The main objective of the current investigation is to evaluate the effect of a single dose
      systemic acetaminophen on postoperative quality of recovery after ambulatory breast surgery.
      We also seek to determine if systemic acetaminophen would decrease postoperative pain and the
      time to hospital discharge in the same population.

      Significance: The current project evaluates a potential intervention to improve perioperative
      pain and recovery after ambulatory breast surgery. Postoperative pain in the ambulatory
      surgical patients has been shown consistently to be poorly managed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be recruited up to the day of surgery. They will be then randomized using a
      computer generated table of random numbers to two groups: Group A (IV acetaminophen 1000 mg
      over 15 minutes at the start of surgical closure) and Group B (placebo group-same volume of
      saline solution administered in the same fashion).This dose has been commonly used in other
      studies involving IV acetaminophen.6 Both drugs will be identical and will be prepared by
      hospital pharmacy. After placement of standard ASA monitors, induction will be performed with
      0.1mcg/kg/min of remifentanil IV, propofol 1.5-2.5 mg/kg IV and succinylcholine 1-2 mg/kg IV.
      Tracheal intubation will be performed using a MAC 3 blade and a size 7 endotracheal tube.
      Maintenance will be achieved with remifentanil infusion titrated to keep the blood pressure
      within 20% of baseline values and sevoflurane titrated to keep a bispectral index monitor
      between 40 and 60. Patients will receive ondansetron 4mg IV and dexamethasone 4 mg IV for
      postoperative nausea and vomiting prophylaxis. In the recovery room patients will receive
      hydromorphone IV in divided doses to keep pain &lt;4/10(scale where 0 means no pain and 10 is
      the worst pain) and metoclopramide 10 mg IV as rescue antiemetic. Data will be collected by a
      research assistant blinded to the group allocation. Data collected will involve pain at PACU
      arrival (NRS-0-10), presence of nausea and vomiting, severity of nausea and vomiting, total
      opioid consumption in PACU, time to discharge using a Modified Postanaesthetic Discharge
      Scoring System (MPADSS) 9, total opioid consumption 24 hours, QoR40 24hours after surgery.8
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Recovery at 24 Hours(QoR-40 Instrument)</measure>
    <time_frame>24 hours after the surgical procedure</time_frame>
    <description>Quality of recovery score 24 hours after the surgical procedure. Total score range of 40 (poor recovery) and a score of 200 (good recovery).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Opioid Consumption</measure>
    <time_frame>24 hour</time_frame>
    <description>Postoperative opioid consumption over 24 hours. Converted into oral mg of morpine equivalents.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain in the Post Anesthesia Care Unit</measure>
    <time_frame>Time in the post anesthesia care unit after surgery (average of 5 hours)</time_frame>
    <description>Postoperative pain within the post anesthesia care unit after surgery. Area under the numeric rating scale for pain versus time curve in the post anesthesia care unit (score * min).Numeric rating scale for pain on a scale of 0-10 (0 is no pain and 10 is high pain) versus time curve in the post anesthesia care unit ( score * min). Area under a curve units of the horizontal axis multiplied by the units of the vertical axis. A higher value indicates more pain and time in the Post Anesthesia Care Unit.The range is 0 pain to x time in minutes x 1 hour to 5 hour ( 60-300 minutes) . The pain scores were collected at 15 minute intervals from the time of admission to the PACU. The area under the NRS pain scale versus time curve was calculated using the trapezoidal method as an indicator of pain burden during early recovery (Graph Pad Prism ver 5.03, Graph Pad Software INC.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>IV acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV acetaminophen</intervention_name>
    <description>Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure</description>
    <arm_group_label>IV acetaminophen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Outpatient lumpectomy

          -  ASA I and II

          -  Age between 18-70

        Exclusion:

          -  Pregnancy

          -  History of liver disease

          -  Unable to understand the informed consent

          -  Chronic pain with use of opioid in the last week

          -  Allergy to acetaminophen

        Drop-out: surgeon or patient request
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gildasio De Oliveira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012 Feb;116(2):248-73. doi: 10.1097/ALN.0b013e31823c1030.</citation>
    <PMID>22227789</PMID>
  </reference>
  <reference>
    <citation>De Oliveira GS Jr, Fitzgerald P, Streicher LF, Marcus RJ, McCarthy RJ. Systemic lidocaine to improve postoperative quality of recovery after ambulatory laparoscopic surgery. Anesth Analg. 2012 Aug;115(2):262-7. doi: 10.1213/ANE.0b013e318257a380. Epub 2012 May 14.</citation>
    <PMID>22584558</PMID>
  </reference>
  <reference>
    <citation>De Oliveira GS Jr, Ahmad S, Fitzgerald PC, Marcus RJ, Altman CS, Panjwani AS, McCarthy RJ. Dose ranging study on the effect of preoperative dexamethasone on postoperative quality of recovery and opioid consumption after ambulatory gynaecological surgery. Br J Anaesth. 2011 Sep;107(3):362-71. doi: 10.1093/bja/aer156. Epub 2011 Jun 13.</citation>
    <PMID>21669954</PMID>
  </reference>
  <reference>
    <citation>De Oliveira GS Jr, Agarwal D, Benzon HT. Perioperative single dose ketorolac to prevent postoperative pain: a meta-analysis of randomized trials. Anesth Analg. 2012 Feb;114(2):424-33. doi: 10.1213/ANE.0b013e3182334d68. Epub 2011 Sep 29. Review.</citation>
    <PMID>21965355</PMID>
  </reference>
  <reference>
    <citation>Cawthorn TR, Phelan R, Davidson JS, Turner KE. Retrospective analysis of perioperative ketorolac and postoperative bleeding in reduction mammoplasty. Can J Anaesth. 2012 May;59(5):466-72. doi: 10.1007/s12630-012-9682-z. Epub 2012 Mar 21.</citation>
    <PMID>22434401</PMID>
  </reference>
  <reference>
    <citation>McNicol ED, Tzortzopoulou A, Cepeda MS, Francia MB, Farhat T, Schumann R. Single-dose intravenous paracetamol or propacetamol for prevention or treatment of postoperative pain: a systematic review and meta-analysis. Br J Anaesth. 2011 Jun;106(6):764-75. doi: 10.1093/bja/aer107. Epub 2011 May 9. Review.</citation>
    <PMID>21558067</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2013</study_first_submitted>
  <study_first_submitted_qc>May 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2013</study_first_posted>
  <results_first_submitted>January 19, 2016</results_first_submitted>
  <results_first_submitted_qc>February 16, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 14, 2016</results_first_posted>
  <last_update_submitted>February 16, 2016</last_update_submitted>
  <last_update_submitted_qc>February 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Gildasio De Oliveira</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Outpatient</keyword>
  <keyword>Surgery</keyword>
  <keyword>Breast</keyword>
  <keyword>Pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IV Acetaminophen</title>
          <description>Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure.
IV acetaminophen: Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen
Placebo: Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IV Acetaminophen</title>
          <description>Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure.
IV acetaminophen: Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen
Placebo: Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="65"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <title>Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" lower_limit="54" upper_limit="65"/>
                    <measurement group_id="B2" value="52" lower_limit="44" upper_limit="68"/>
                    <measurement group_id="B3" value="55" lower_limit="44" upper_limit="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quality of Recovery at 24 Hours(QoR-40 Instrument)</title>
        <description>Quality of recovery score 24 hours after the surgical procedure. Total score range of 40 (poor recovery) and a score of 200 (good recovery).</description>
        <time_frame>24 hours after the surgical procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure.
IV acetaminophen: Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen
Placebo: Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Recovery at 24 Hours(QoR-40 Instrument)</title>
          <description>Quality of recovery score 24 hours after the surgical procedure. Total score range of 40 (poor recovery) and a score of 200 (good recovery).</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="189" lower_limit="183" upper_limit="194"/>
                    <measurement group_id="O2" value="183" lower_limit="175" upper_limit="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.01</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Opioid Consumption</title>
        <description>Postoperative opioid consumption over 24 hours. Converted into oral mg of morpine equivalents.</description>
        <time_frame>24 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure.
IV acetaminophen: Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen
Placebo: Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Opioid Consumption</title>
          <description>Postoperative opioid consumption over 24 hours. Converted into oral mg of morpine equivalents.</description>
          <units>oral mg of morpine equivalents</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="10" upper_limit="30"/>
                    <measurement group_id="O2" value="30" lower_limit="10" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.04</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Pain in the Post Anesthesia Care Unit</title>
        <description>Postoperative pain within the post anesthesia care unit after surgery. Area under the numeric rating scale for pain versus time curve in the post anesthesia care unit (score * min).Numeric rating scale for pain on a scale of 0-10 (0 is no pain and 10 is high pain) versus time curve in the post anesthesia care unit ( score * min). Area under a curve units of the horizontal axis multiplied by the units of the vertical axis. A higher value indicates more pain and time in the Post Anesthesia Care Unit.The range is 0 pain to x time in minutes x 1 hour to 5 hour ( 60-300 minutes) . The pain scores were collected at 15 minute intervals from the time of admission to the PACU. The area under the NRS pain scale versus time curve was calculated using the trapezoidal method as an indicator of pain burden during early recovery (Graph Pad Prism ver 5.03, Graph Pad Software INC.</description>
        <time_frame>Time in the post anesthesia care unit after surgery (average of 5 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure.
IV acetaminophen: Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen
Placebo: Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain in the Post Anesthesia Care Unit</title>
          <description>Postoperative pain within the post anesthesia care unit after surgery. Area under the numeric rating scale for pain versus time curve in the post anesthesia care unit (score * min).Numeric rating scale for pain on a scale of 0-10 (0 is no pain and 10 is high pain) versus time curve in the post anesthesia care unit ( score * min). Area under a curve units of the horizontal axis multiplied by the units of the vertical axis. A higher value indicates more pain and time in the Post Anesthesia Care Unit.The range is 0 pain to x time in minutes x 1 hour to 5 hour ( 60-300 minutes) . The pain scores were collected at 15 minute intervals from the time of admission to the PACU. The area under the NRS pain scale versus time curve was calculated using the trapezoidal method as an indicator of pain burden during early recovery (Graph Pad Prism ver 5.03, Graph Pad Software INC.</description>
          <units>(units on a scale * minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="255" lower_limit="225" upper_limit="300"/>
                    <measurement group_id="O2" value="240" lower_limit="180" upper_limit="300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.36</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Development of nausea 24 hours after surgery.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>IV Acetaminophen</title>
          <description>Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure.
IV acetaminophen: Administration of IV acetaminophen 1000 mg over 15 minutes at the start of surgical closure</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen
Placebo: Administration of placebo (sterile normal saline)group-same volume of saline solution administered in the same fashion as the acetaminophen</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>Vomiting</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomiting</sub_title>
                <description>Vomiting within 24 hours of surgery</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title vocab="MedDRA (10.0)">Nausea</sub_title>
                <description>Nausea within 24 hours of surgery</description>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="33"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Gildasio De Oliveira, M.D.</name_or_title>
      <organization>Northwestern University</organization>
      <phone>312-695-4858</phone>
      <email>gjr@northwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

